A Gammaherpesvirus Uses Alternative Splicing to Regulate Its Tropism and Its Sensitivity to Neutralization

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Machiels, Bénédicte ^a   Stevenson, Philip G ^b   Vanderplasschen, Alain ^a   Gillet, Laurent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CD14 ANTIGEN; EPITOPE; GLYCOSAMINOGLYCAN; GP180 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS GLYCOPROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANTIGENICITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BO10 GENE; BOVINE HERPESVIRUS 4; CONTROLLED STUDY; COW; FLOW CYTOMETRY; GAMMAHERPESVIRINAE; IMMUNOBLOTTING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRAL TROPISM; VIRION; VIRUS GENE; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS STRAIN; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, CD14; CATTLE; CELL LINE; HERPESVIRUS 4, BOVINE; HUMANS; RABBITS; VIRAL PROTEINS;

EID: 84887286219     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003753     Document Type: Article

References (52)

1. Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, et al. (1969) Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43: 1147-1157.
2. Verma SC, Robertson ES, (2003) Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222: 155-163.
3. Young LS, Rickinson AB, (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
4. Mesri EA, Cesarman E, Boshoff C, (2010) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10: 707-719.
5. Heldwein EE, Krummenacher C, (2008) Entry of herpesviruses into mammalian cells. Cell Mol Life Sci 65: 1653-1668.
6. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R, (2011) Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol 9: 369-381.
7. Gillet L, May JS, Colaco S, Stevenson PG, (2007) Glycoprotein L disruption reveals two functional forms of the murine gammaherpesvirus 68 glycoprotein H. J Virol 81: 280-291.
8. Hutt-Fletcher LM, (2007) Epstein-Barr virus entry. J Virol 81: 7825-7832.
9. Tanner J, Weis J, Fearon D, Whang Y, Kieff E, (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50: 203-213.
10. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ, (2006) Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 103: 7065-7070.
11. Turk SM, Jiang R, Chesnokova LS, Hutt-Fletcher LM, (2006) Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol 80: 9628-9633.
12. Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, et al. (1996) The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol 70: 5557-5563.
13. Mullen MM, Haan KM, Longnecker R, Jardetzky TS, (2002) Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell 9: 375-385.
14. Kirschner AN, Sorem J, Longnecker R, Jardetzky TS, (2009) Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptor-activated virus entry. Structure 17: 223-233.
15. Wang X, Kenyon WJ, Li Q, Mullberg J, Hutt-Fletcher LM, (1998) Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol 72: 5552-5558.
16. Li Q, Spriggs MK, Kovats S, Turk SM, Comeau MR, et al. (1997) Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71: 4657-4662.
17. Wang X, Hutt-Fletcher LM, (1998) Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J Virol 72: 158-163.
18. Borza CM, Hutt-Fletcher LM, (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8: 594-599.
19. Hutt-Fletcher LM, Chesnokova LS, (2010) Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection. Virulence 1: 395-398.
20. Raab MS, Albrecht JC, Birkmann A, Yaguboglu S, Lang D, et al. (1998) The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 72: 6725-6731.
21. Stewart JP, Janjua NJ, Pepper SD, Bennion G, Mackett M, et al. (1996) Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70: 3528-3535.
22. Machiels B, Lete C, de Fays K, Mast J, Dewals B, et al. (2011) The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects. J Virol 85: 1011-1024.
23. de Lima BD, May JS, Stevenson PG, (2004) Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol 78: 5103-5112.
24. Wang FZ, Akula SM, Pramod NP, Zeng L, Chandran B, (2001) Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75: 7517-7527.
25. Gillet L, Adler H, Stevenson PG, (2007) Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS One 2: e347.
26. Blasig C, Zietz C, Haar B, Neipel F, Esser S, et al. (1997) Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 71: 7963-7968.
27. Fabian K, Ivanics R, Terenyi M, Egyed L, (2005) Detection of bovine herpesvirus 4 in CD11b+ leukocytes of experimentally infected rabbits. Acta Vet Hung 53: 265-273.
28. Zimmermann W, Broll H, Ehlers B, Buhk HJ, Rosenthal A, et al. (2001) Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. J Virol 75: 1186-1194.
29. Thorley-Lawson DA, Poodry CA, (1982) Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol 43: 730-736.
30. Machiels B, Lete C, Guillaume A, Mast J, Stevenson PG, et al. (2011) Antibody evasion by a gammaherpesvirus O-glycan shield. PLoS Pathog 7: e1002387.
31. Kolset SO, (1987) Proteoglycans in normal and neoplastic monocytes. Exp Cell Res 168: 318-324.
32. Milho R, Frederico B, Efstathiou S, Stevenson PG, (2012) A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry. PLoS Pathog 8: e1002986.
33. Francois S, Vidick S, Sarlet M, Desmecht D, Drion P, et al. (2013) Illumination of Murine Gammaherpesvirus-68 Cycle Reveals a Sexual Transmission Route from Females to Males in Laboratory Mice. PLoS Pathog 9: e1003292.
34. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA, (2009) The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5: e1000496.
35. May JS, Coleman HM, Smillie B, Efstathiou S, Stevenson PG, (2004) Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol 85: 137-146.
36. Frederico B, Milho R, May JS, Gillet L, Stevenson PG, (2012) Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. PLoS Pathog 8: e1002935.
37. Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, et al. (2013) Defining influenza a virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe 13: 314-323.
38. Sattentau Q, (2008) Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6: 815-826.
39. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST, (1996) The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 93: 3602-3607.
40. Ito H, Watanabe S, Takada A, Kawaoka Y, (2001) Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol 75: 1576-1580.
41. Mohan GS, Li W, Ye L, Compans RW, Yang C, (2012) Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus. PLoS Pathog 8: e1003065.
42. Birkmann A, Mahr K, Ensser A, Yaguboglu S, Titgemeyer F, et al. (2001) Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 75: 11583-11593.
43. Concha M, Wang X, Cao S, Baddoo M, Fewell C, et al. (2012) Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq. J Virol 86: 1458-1467.
44. Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, et al. (2012) Decoding human cytomegalovirus. Science 338: 1088-1093.
45. Gatherer D, Seirafian S, Cunningham C, Holton M, Dargan DJ, et al. (2011) High-resolution human cytomegalovirus transcriptome. Proc Natl Acad Sci U S A 108: 19755-19760.
46. van Beurden SJ, Gatherer D, Kerr K, Galbraith J, Herzyk P, et al. (2012) Anguillid herpesvirus 1 transcriptome. J Virol 86: 10150-10161.
47. Jarosinski KW, Osterrieder N, (2012) Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission. J Virol 86: 7896-7906.
48. Thiry E, Pastoret PP, Dessy-Doizé C, Hanzen C, Calberg-Bacq CM, (1981) Herpesvirus in infertile bull's testicle. Vet rec 108: 426.
49. Gillet L, Daix V, Donofrio G, Wagner M, Koszinowski UH, et al. (2005) Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. J Gen Virol 86: 907-917.
50. Donofrio G, van Santen VL, (2001) A bovine macrophage cell line supports bovine herpesvirus-4 persistent infection. J Gen Virol 82: 1181-1185.
51. Palmeira L, Machiels B, Lete C, Vanderplasschen A, Gillet L, (2011) Sequencing of bovine herpesvirus 4 v.test strain reveals important genome features. Virol J 8: 406.
52. Lete C, Machiels B, Stevenson PG, Vanderplasschen A, Gillet L, (2012) Bovine herpesvirus type 4 glycoprotein L is nonessential for infectivity but triggers virion endocytosis during entry. J Virol 86: 2653-2664.